In a relief to FMCG major Dabur, two of its foreign subsidiaries, Dabur International and Dermoviva Skin Essentials, have been removed as a defendant in multiple lawsuits filed in a US court over allegations that their hair-relaxer products caused ovarian cancer, uterine cancer and other related health issues. However, lawsuits filed against its third international subsidiary Namaste Laboratories LLC, would continue before the US District Court for the Northern District of Illinois, according to a statement from Dabur on Wednesday. Dabur International and Dermoviva were removed and got relief in the multiple suits due to lack of jurisdiction as they have not either manufactured, marketed, distributed or sold hair relaxer products in the US, it added.
Harris, 59, is scheduled to formally accept the Democratic Party's presidential nomination on Thursday to take on Republican rival Donald Trump, 78, in the November 5 election.
Dahiya's first internet-based venture to sell insurance failed, but he was convinced digital was the future
The Federal Bureau of Investigation has launched a nationwide manhunt and alerted Interpol to locate one of its most-wanted fugitives, Indian-origin doctor Gautam Gupta whose ads promising weight loss are well-known, for allegedly defrauding United States insurance companies of $25 million over the last decade.
The New Delhi-born Krishnamoorthi, a lifelong progressive, was always the front-runner in the race against Republican Peter DiCianni. They were vying for the seat vacated by Tammy Duckworth, who won Illinois's US Senate seat.
'Today we prove that our democracy still works and that the power always belongs to the people through the power of our vote'
Aaron Schock, who resigned as US Congressman on Tuesday night following media disclosures of his loose spending habits, met Narendra Modi thrice. These encounters were not free of controversy either.
In his penultimate State of the Union address, Barack Obama said that the economy is improving.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances